Immune response and its correlation with the disease activity in patients with advanced colorectal cancer (aCRC): Results from a prospective observational study.
Shahid Ahmed(Emory University), Peter A. Bretscher(University of Saskatchewan), Lynn Dwernychuck(Saskatchewan Cancer Agency), F Arnold(University of Saskatchewan), Guojian Wei(University of Saskatchewan), Kamal Haider(University of Saskatchewan), Nayyar Iqbal(Chinese University of Hong Kong), June Lim(University of Saskatchewan), Tahir Abbas(University of Saskatchewan), Sunil Kumar Yadav(University of Saskatchewan), Amer Sami(University of Saskatchewan)
Cited by 2
Related Papers
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
|The Lancet Diabetes & Endocrinology|2017|591
Gallbladder Cancer in the 21st Century
|Journal of Oncology|2015|301